Cargando…

Effect of glycemic control on markers of subclinical atherosclerosis in patients with type 2 diabetes mellitus: A review

Cardiovascular disease is the predominant cause of death in type 2 diabetes mellitus (T2DM). Evidence suggests a strong association between duration and degree of hyperglycemia and vascular disease. However, large trials failed to show cardiovascular benefit after intensive glycemic control, especia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Antoniou, Sofia, Naka, Katerina K, Papadakis, Marios, Bechlioulis, Aris, Tsatsoulis, Agathocles, Michalis, Lampros K, Tigas, Stelios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613661/ https://www.ncbi.nlm.nih.gov/pubmed/34888012 http://dx.doi.org/10.4239/wjd.v12.i11.1856

Ejemplares similares

Relationship between Indices of Vascular Function and Presence of Overt Cardiovascular Disease among Persons with Poorly Controlled Type 2 Diabetes
por: Antoniou, Sofia, et al.
Publicado: (2021)

Determinants of vascular function in patients with type 2 diabetes
por: Naka, Katerina K, et al.
Publicado: (2012)

Endocrine and metabolic manifestations in inflammatory bowel disease
por: Tigas, Stelios, et al.
Publicado: (2012)

Familial partial lipodystrophy and proteinuric renal disease due to a missense c.1045C > T LMNA mutation
por: Fountas, Athanasios, et al.
Publicado: (2017)

6-minute walking test: a useful tool in the management of heart failure patients
por: Giannitsi, Sophia, et al.
Publicado: (2019)

Brugada syndrome in a young patient with type 1 myotonic dystrophy requiring an implantable cardioverter defibrillator for primary prevention: a case report
por: Korantzopoulos, Panagiotis, et al.
Publicado: (2019)

Lack of effects of pioglitazone on cardiac function in patients with type 2 diabetes and evidence of left ventricular diastolic dysfunction: a tissue doppler imaging study
por: Naka, Katerina K, et al.
Publicado: (2010)

Association of fibroblast growth factor 21 with metabolic syndrome and endothelial function in children: a prospective cross-sectional study on novel biomarkers
por: Domouzoglou, Eleni M., et al.
Publicado: (2021)

Multiple arterial aneurysms coexisting with giant right coronary artery aneurysm: an easy diagnosis by non-invasive imaging methods
por: Bouratzis, Vasileios, et al.
Publicado: (2023)

Ascending aorta thrombosis in a patient with COVID-19 who was already receiving anticoagulation therapy
por: Bouratzis, Vasileios, et al.
Publicado: (2023)

The Role of Myocardial Perfusion Imaging in the Prediction of Major Adverse Cardiovascular Events at 1 Year Follow-Up: A Single Center’s Experience
por: Zotou, Paraskevi, et al.
Publicado: (2023)

The Role of Insulin Resistance/Hyperinsulinism on the Rising Trend of Thyroid and Adrenal Nodular Disease in the Current Environment
por: Tsatsoulis, Agathocles
Publicado: (2018)

Endothelial dysfunction and heart failure: A review of the existing bibliography with emphasis on flow mediated dilation
por: Giannitsi, Sofia, et al.
Publicado: (2019)

Differences in the Profile of Circulating Immune Cell Subsets in Males with Type 2 Cardiorenal Syndrome versus CKD Patients without Established Cardiovascular Disease
por: Duni, Anila, et al.
Publicado: (2023)

A Machine Learning Approach for Chronic Heart Failure Diagnosis
por: Plati, Dafni K., et al.
Publicado: (2021)

The Potential Role of Salivary NT-proBNP in Heart Failure
por: Rammos, Aidonis, et al.
Publicado: (2023)

Visceral Adiposity Index as an Independent Marker of Subclinical Atherosclerosis in Individuals Prone to Diabetes Mellitus
por: Randrianarisoa, Elko, et al.
Publicado: (2019)

Glycemic variability is associated with subclinical atherosclerosis in Chinese type 2 diabetic patients
por: Mo, Yifei, et al.
Publicado: (2013)

Body Mass Index Is Independently Associated with the Presence of Ischemia in Myocardial Perfusion Imaging
por: Sioka, Chrissa, et al.
Publicado: (2022)

Role of Surrogate Markers of Atherosclerosis in Clinical and Subclinical Thyroidism
por: Gunduz, Mehmet, et al.
Publicado: (2012)

Chemerin is not associated with subclinical atherosclerosis markers in prediabetes and diabetes
por: Aydın, Kadriye, et al.
Publicado: (2016)

Assessment of Noninvasive Risk Markers of Subclinical Atherosclerosis in Premenopausal Women with Previous History of Gestational Diabetes Mellitus
por: Karoli, Ritu, et al.
Publicado: (2015)

Salivary Biomarkers for Diagnosis and Therapy Monitoring in Patients with Heart Failure. A Systematic Review
por: Rammos, Aidonis, et al.
Publicado: (2021)

Clinical and imaging evaluation of the response to intravenous steroids in patients with Graves’ orbitopathy and analysis on who requires additional therapy
por: Tsirouki, Theodora, et al.
Publicado: (2016)

Focus on the research utility of intravascular ultrasound - comparison with other invasive modalities
por: Bourantas, Christos V, et al.
Publicado: (2011)

Circulating Tryptase as a Marker for Subclinical Atherosclerosis in Obese Subjects
por: Moreno, María, et al.
Publicado: (2014)

Erosive Hand Osteoarthritis is Associated with Subclinical Atherosclerosis and Endothelial Dysfunction
por: Koutroumpas, Athanasios, et al.
Publicado: (2013)

Allantoin as an independent marker associated with carotid intima-media thickness in subclinical atherosclerosis
por: Santana, M.S., et al.
Publicado: (2018)

PECAM-1 gene polymorphism (rs668) and subclinical markers of carotid atherosclerosis in patients with type 2 diabetes mellitus
por: Popović, D, et al.
Publicado: (2016)

Perirenal fat thickness as a superior obesity-related marker of subclinical carotid atherosclerosis in type 2 diabetes mellitus
por: Guo, Xiu Li, et al.
Publicado: (2023)

Epicardial fat: a novel marker of subclinical atherosclerosis in clinical practice?
por: Katsiki, Niki, et al.
Publicado: (2017)

Serum irisin and apelin levels and markers of atherosclerosis in patients with subclinical hypothyroidism
por: Yasar, Hamiyet Yilmaz, et al.
Publicado: (2019)

Inflammatory Markers Used as Predictors of Subclinical Atherosclerosis in Patients with Diabetic Polyneuropathy
por: Mureșan, Adrian Vasile, et al.
Publicado: (2023)

Exercise-mediated adaptations in vascular function and structure: Beneficial effects in coronary artery disease
por: Sakellariou, Xenofon M, et al.
Publicado: (2021)

Subclinical atherosclerosis in patients with psoriasis
por: Balta, Ilknur, et al.
Publicado: (2015)

Diabetes and Subclinical Coronary Atherosclerosis
por: Lee, Chang Hoon, et al.
Publicado: (2018)

Predictors of subclinical atherosclerosis in HIV
por: Fernández Soto, Julia, et al.
Publicado: (2023)

Poor glycemic control is associated with the risk of subclinical hypothyroidism in patients with type 2 diabetes mellitus
por: Cho, Jae Ho, et al.
Publicado: (2016)

Association of α-klotho with subclinical carotid atherosclerosis in subjects with type 1 diabetes mellitus
por: Castelblanco, Esmeralda, et al.
Publicado: (2022)

Impact of hypertension on various markers of subclinical atherosclerosis in early type 2 diabetes
por: Alatab, Sudabeh, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_t9f511h8c7kekluljcqjne7lmp